Location History:
- Geneva, CH (1999)
- Chenes bou Geries, CH (2006)
Company Filing History:
Years Active: 1999-2006
Title: Innovations by Jean-Marie Tiercy
Introduction
Jean-Marie Tiercy is a notable inventor based in Chenes bou Geries, Switzerland. He has made significant contributions to the field of genetic analysis, holding 2 patents that focus on methods for analyzing genetic predispositions to diseases.
Latest Patents
One of his latest patents is a method for analyzing a patient's genetic predisposition to at least one disease. This innovative approach involves placing, in the presence of probes, at least one type of amplicon derived from the amplification of a polymorphic region of nucleic acid from the patient. The polymorphic region is specifically chosen based on its relevance to the disease being investigated. The method utilizes both low-resolution typing probes and high-resolution subtyping probes to distinguish between alleles associated with susceptibility and resistance to diseases.
Another significant patent is a system of probes enabling HLA-DR typing to be performed. This set of probes is designed for determining HLA-DR types or sub-types, which are crucial for understanding immune responses and disease susceptibility.
Career Highlights
Jean-Marie Tiercy is currently associated with bioMérieux, Inc., a company renowned for its expertise in diagnostics and biotechnology. His work at bioMérieux has allowed him to contribute to advancements in medical diagnostics, particularly in the realm of genetic testing.
Collaborations
Throughout his career, Tiercy has collaborated with esteemed colleagues such as Patrice A Allibert and Philippe Cros. These collaborations have further enriched his research and innovations in genetic analysis.
Conclusion
Jean-Marie Tiercy's contributions to genetic analysis through his patents reflect his commitment to advancing medical science. His innovative methods have the potential to significantly impact the understanding and treatment of genetic diseases.